{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:58:40Z","timestamp":1781632720204,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic hepatitis B (HBV) and hepatitis C (HCV) pose significant public health challenges in Viet Nam and the Philippines. Both countries have initiated national strategies aimed at decentralizing hepatitis care to primary healthcare facilities, but the availability and readiness of these facilities to manage hepatitis remains unclear. This study aimed to evaluate the availability and readiness of primary care facilities in Viet Nam and the Philippines to provide comprehensive hepatitis services and to identify key gaps in care delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mixed-methods approach was used, combining health facility surveys and focus group discussions (FGDs) with healthcare workers to assess service availability and identify barriers and enablers of hepatitis care. Data were collected from 18 health facilities and 36 healthcare workers through 6 FGDs across both countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study identified critical gaps in hepatitis service availability, healthcare worker training, diagnostic capacities, and community engagement at the primary care level. While provincial level facilities were well-equipped, most primary care facilities lacked essential resources such as viral load testing, medications, and adequately trained healthcare workers. A key barrier was the lack of social health insurance coverage or reimbursement for hepatitis services at the primary care level in both countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Gaps identified may require coordinated action from both national and subnational stakeholders. Expanding social health insurance coverage to include hepatitis services at the primary care level, improving healthcare worker training and support, and ensuring the availability of diagnostics and antivirals at the primary care level are essential steps to meet the 2030 hepatitis elimination targets in Viet Nam and the Philippines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-026-14088-y","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T03:44:15Z","timestamp":1770003855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Healthcare system readiness to manage viral hepatitis in Viet Nam and the Philippines: results of a brief health facility assessment"],"prefix":"10.1186","volume":"26","author":[{"given":"Martin Louis","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geohari","family":"Hamoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhaki","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Bill","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Joy","family":"Cabauatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Michael","family":"Manlutac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Philip","family":"Florendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Delima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Cris","family":"Rombaoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mateo","family":"Dela Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Buccahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hjordis Marushka","family":"Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Lazatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Nam","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Xuan","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Khanh","family":"Thu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"8","key":"14088_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"Y-C Hsu","year":"2023","unstructured":"Hsu Y-C, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"14088_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S2468-1253(23)00408-9","volume":"9","author":"K Heath","year":"2024","unstructured":"Heath K, Hill A. WHO hepatitis C elimination targets: the global equity challenge. Lancet Gastroenterol Hepatol. 2024;9(4):286\u201388.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"14088_CR3","unstructured":"Hepatitis B. n.d. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Retrieved July 26, 2024, from."},{"key":"14088_CR4","unstructured":"Hepatitis C. n.d. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c. Retrieved April 10, 2024, from."},{"issue":"1","key":"14088_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"issue":"9","key":"14088_CR6","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/liv.15251","volume":"42","author":"C-H Zhang","year":"2022","unstructured":"Zhang C-H, Cheng Y, Zhang S, Fan J, Gao Q. Changing epidemiology of hepatocellular carcinoma in Asia. Liver Int: Off J Int Assoc Study Liver. 2022;42(9):2029\u201341.","journal-title":"Liver Int: Off J The Int Assoc The Study The Liver"},{"key":"14088_CR7","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. World Health Organ. 2022. https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/strategies\/global-health-sector-strategies\/developing-ghss-2022-2030."},{"key":"14088_CR8","unstructured":"Countries dashboard - CDA foundation. n.d. https:\/\/cdafound.org\/polaris-countries-dashboard\/#footnote-hcv. Retrieved July 26, 2024, from."},{"key":"14088_CR9","doi-asserted-by":"crossref","unstructured":"Holt B, Fernandez M, Nguyen D, Delima D, Duy LD, Gaspar M, et al., \u2026 Duong D. Embedding viral hepatitis into primary healthcare: results of a strategic landscape analysis in Vietnam and the Philippines. Lancet Reg Health West Pac. 2024;44:100990.","DOI":"10.1016\/j.lanwpc.2023.100990"},{"issue":"14","key":"14088_CR10","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.vaccine.2021.02.042","volume":"39","author":"AA Minta","year":"2021","unstructured":"Minta AA, Silva MWT, Shrestha A, de Quiroz-Castro M, Tohme RA, Quimson ME 4th, et al. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018. Vaccine. 2021;39(14):1982\u201389.","journal-title":"Vaccine"},{"issue":"10","key":"14088_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"Polaris Observatory Collaborators","year":"2023","unstructured":"Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879\u2013907.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"14088_CR12","doi-asserted-by":"crossref","unstructured":"Thinh VT, Phuong DT, Hoa VD, Giang LM. Reported low uptake of HCV testing among people who inject drugs in urban Vietnam. Biomed Res Int. 2020, 2020;3701379.","DOI":"10.1155\/2020\/3701379"},{"key":"14088_CR13","unstructured":"Initiative to improve management of viral hepatitis in Vietnam and the Philippines. 2023 March 3. https:\/\/globalhealthprogress.org\/collaboration\/initiative-to-improve-management-of-viral-hepatitis-in-vietnam-and-the-philippines\/). Global Health Progress."},{"key":"14088_CR14","unstructured":"Prevention and control of hepatitis B and hepatitis C in the Philippines: A call to action. Coalition for global hepatitis elimination. n.d.. https:\/\/www.globalhep.org\/tools-resources\/action-plans\/prevention-and-control-hepatitis-b-and-hepatitis-c-philippines-call. Retrieved April 10, 2024, from."},{"key":"14088_CR15","unstructured":"Implementation progress of the regional action plan for viral hepatitis in the Western Pacific 2016-2020. n.d. https:\/\/www.who.int\/westernpacific\/health-topics\/hepatitis\/implementation-progress-of-the-regional-action-plan-for-viral-hepatitis-in-the-western-pacific-2016-2020. Retrieved April 10, 2024, from."},{"key":"14088_CR16","unstructured":"Ministry of Health. Decision no. 4531\/QD-BYT on national viral hepatitis prevention plan for the period 2021 - 2025. Hanoi, Vietnam; 2021."},{"key":"14088_CR17","volume-title":"Situational analysis of the viral hepatitis response in the Philippines for evidence-informed policy-making in the context of universal healthcare law","author":"World Health Organization, & Department of Health","year":"2022","unstructured":"World Health Organization, & Department of Health. Situational analysis of the viral hepatitis response in the Philippines for evidence-informed policy-making in the context of universal healthcare law. WHO; 2022."},{"key":"14088_CR18","volume-title":"Department Memorandum No. 2020-0531. Interim guidelines on the management of patients diagnosed with hepatitis C","author":"Department of Health","year":"2020","unstructured":"Department of Health. Department Memorandum No. 2020-0531. Interim guidelines on the management of patients diagnosed with hepatitis C. Department of Health; 2020."},{"key":"14088_CR19","volume-title":"Department Memorandum No. 2020-0532. Revised Interim guidelines on the management of patients with hepatitis B infection","author":"Department of Health","year":"2020","unstructured":"Department of Health. Department Memorandum No. 2020-0532. Revised Interim guidelines on the management of patients with hepatitis B infection. Department of Health; 2020."},{"key":"14088_CR20","unstructured":"MOH. Decision No. 3310\/Q\u0110-BYT Ministry of health on the Issuance of guidelines for the diagnosis and treatment of viral hepatitis B. Ministry of Health; 2019. https:\/\/thuvienphapluat.vn\/van-ban\/The-thao-Y-te\/Quyet-dinh-3310-QD-BYT-2019-huong-dan-chan-doan-dieu-tri-benh-viem-gan-vi-rut-B-419819.aspx%26sa=D%26source=docs%26ust=173344782254237%26usg=AOvVaw2w5z4LMBdrUce9u2m4LyK7."},{"key":"14088_CR21","volume-title":"Decision No. 2065\/Q\u0110-BYT Ministry of health on the Issuance of guidelines for the diagnosis and treatment of viral hepatitis C","author":"MOH","year":"2021","unstructured":"MOH. Decision No. 2065\/Q\u0110-BYT Ministry of health on the Issuance of guidelines for the diagnosis and treatment of viral hepatitis C. Ministry of Health; 2021. https:\/\/thuvienphapluat.vn\/van-ban\/The-thao-Y-te\/Quyet-dinh-2065-QD-BYT-2021-huong-dan-chan-doan-dieu-tri-benh-viem-gan-vi-rut-C-472720.aspx%26sa=D%26source=docs%26ust=1733447822542411%26usg=AOvVaw1FRouBaXTh34CsRwwVzCdn."},{"key":"14088_CR22","volume-title":"Harmonize health facility assessment (HHFA): comprehensive guide","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Harmonize health facility assessment (HHFA): comprehensive guide. (World Health Organization (Ed.)). World Health Organization; 2023."},{"key":"14088_CR23","unstructured":"Harmonized health facility assessment (HHFA): comprehensive Guide. 2023 January 9. https:\/\/www.who.int\/publications\/i\/item\/9789240060302). World Health Organization."},{"key":"14088_CR24","unstructured":"Central Luzon (Region III) Profile - PhilAtlas. PhilAtlas. n.d.. https:\/\/www.philatlas.com\/luzon\/r03.html. Retrieved April 10, 2024, from."},{"key":"14088_CR25","unstructured":"Usaid DOH, RTI International. Tarlac. USAID; n.d. https:\/\/pdf.usaid.gov\/pdf_docs\/PA00TJ4V.pdf."},{"key":"14088_CR26","unstructured":"I. PhilAtlas. n.d. https:\/\/www.philatlas.com\/luzon\/r03\/tarlac.html. Retrieved April 10, 2024, from."},{"key":"14088_CR27","unstructured":"I. PhilAtlas. n.d. https:\/\/www.philatlas.com\/luzon\/r03\/bataan.html. Retrieved April 10, 2024, from."},{"key":"14088_CR28","unstructured":"PhilAtlas. Bulacan. PhilAtlas. n.d.. https:\/\/www.philatlas.com\/luzon\/r03\/bulacan.html. Retrieved April 10, 2024, from."},{"key":"14088_CR29","unstructured":"Doh USAID, RTI International. Bulacan. USAID; n.d. https:\/\/pdf.usaid.gov\/pdf_docs\/PA00THW2.pdf."},{"key":"14088_CR30","unstructured":"WHO. Hospitals in Viet Nam. World Health Organization; n.d. https:\/\/www.who.int\/vietnam\/health-topics\/hospitals."},{"key":"14088_CR31","unstructured":"DoH TB. Annual health sector report. 2023. Thai Binh DoH."},{"key":"14088_CR32","unstructured":"World Health Organization. Service availability and readiness assessment (SARA): an annual monitoring system for service delivery. 2015. https:\/\/iris.who.int\/bitstream\/handle\/10665\/149025\/WHO_HIS_HSI_2014.5_eng.pdf?sequence=1."},{"issue":"1","key":"14088_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13012-021-01111-5","volume":"16","author":"AL Nevedal","year":"2021","unstructured":"Nevedal AL, Reardon CM, Opra Widerquist MA, Jackson GL, Cutrona SL, White BS, et al. Rapid versus traditional qualitative analysis using the consolidated framework for implementation Research (CFIR). Implementation Sci: IS. 2021;16(1):67.","journal-title":"Implementation Sci: IS"},{"issue":"6","key":"14088_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","volume":"9","author":"PJ Easterbrook","year":"2024","unstructured":"Easterbrook PJ, Luhmann N, Bajis S, Min MS, Newman M, Lesi O, et al. WHO, 2024 hepatitis B guidelines: an opportunity to transform care. Lancet Gastroenterol Hepatol. 2024;9(6):493\u201395.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"14088_CR35","unstructured":"Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection. 2022 June 24. https:\/\/www.who.int\/publications\/i\/item\/9789240052697). Geneva: World Health Organization."},{"issue":"4","key":"14088_CR36","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","volume":"9","author":"E Oru","year":"2021","unstructured":"Oru E, Trickey A, Shirali R, Kanters S, Easterbrook P. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis. Lancet Global Health. 2021;9(4):e431\u201345.","journal-title":"Lancet Global Health"},{"issue":"4","key":"14088_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S2468-1253(21)00467-2","volume":"7","author":"MB Klein","year":"2022","unstructured":"Klein MB. Simplifying HCV treatment: a pathway to elimination and model for delivering healthcare to vulnerable populations. Lancet Gastroenterol Hepatol. 2022;7(4):277\u201379.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"14088_CR38","doi-asserted-by":"publisher","first-page":"e0223733","DOI":"10.1371\/journal.pone.0223733","volume":"14","author":"TT Hang Pham","year":"2019","unstructured":"Hang Pham TT, Le TX, Nguyen DT, Luu CM, Truong BD, Tran PD, et al. Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam. PLoS One. 2019;14(10):e0223733.","journal-title":"PLoS One"},{"issue":"1","key":"14088_CR39","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1186\/s12913-023-09849-y","volume":"23","author":"MA Corcorran","year":"2023","unstructured":"Corcorran MA, Thornton K, Struminger B, Easterbrook P, Scott JD. Training the healthcare workforce: the global experience with telementorship for hepatitis B and hepatitis C. BMC Health Serv Res. 2023;23(1):824.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"14088_CR40","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12913-023-09777-x","volume":"23","author":"MA Corcorran","year":"2023","unstructured":"Corcorran MA, Scott JD, Naveira M, Easterbrook P. Training the healthcare workforce to support task-shifting and viral hepatitis elimination: a global review of English language online trainings and in-person workshops for management of hepatitis B and C infection. BMC Health Serv Res. 2023;23(1):849.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"14088_CR41","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jceh.2021.12.006","volume":"12","author":"MK Behera","year":"2022","unstructured":"Behera MK, Nath P, Behera SK, Padhi PK, Singh A, Singh SP. Unemployment and illiteracy are predictors of hepatitis B virus-related stigma and discrimination. J Clin Exp Hepatol. 2022;12(3):767\u201373.","journal-title":"J Clin Exp Hepatol"},{"issue":"12","key":"14088_CR42","first-page":"796","volume":"20","author":"I Rafique","year":"2015","unstructured":"Rafique I, Saqib MAN, Siddiqui S, Munir MA, Qureshi H, Javed N, et al. Experiences of stigma among hepatitis B and C patients in Rawalpindi and Islamabad, Pakistan. La Revue de Sante de La Mediterranee Orientale [East Mediterranean Health J]. 2015;20(12):796\u2013803.","journal-title":"La Revue de Sante de La Mediterranee Orientale [East Mediterranean Health J]"},{"key":"14088_CR43","doi-asserted-by":"crossref","unstructured":"Van Kim T, Pham TND, Phan P, Le MHN, Le Q, Nguyen PT, et al. Effectiveness and implementation of decentralized, community- and primary care-based strategies in promoting hepatitis B testing uptake: a systematic review and meta-analysis. 2024 July 13. https:\/\/www.unboundmedicine.com\/medline\/citation\/39309722\/Effectiveness_and_implementation_of_decentralized,_community-_and_primary_care-based_strategies_in_promoting_hepatitis_B_testing_uptake:_a_systematic_review_and_meta-analysis. PRIME PubMed.","DOI":"10.1016\/j.eclinm.2024.102818"},{"key":"14088_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/try117","volume-title":"Hepatitis B assessment without hepatitis B virus DNA quantification: a prospective cohort study in Uganda","author":"N Laing","year":"2018","unstructured":"Laing N, Tufton H, Ochola E, P\u2019Kingston OG, Maini MK, Easom N. Hepatitis B assessment without hepatitis B virus DNA quantification: a prospective cohort study in Uganda. Oxford Academic; Trans R Soc Trop Med Hyg; 2018 November 17. https:\/\/doi.org\/10.1093\/trstmh\/try117."},{"key":"14088_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.antiviral.2015.01.004","volume":"119","author":"CS Graham","year":"2015","unstructured":"Graham CS, Swan T. A path to eradication of hepatitis C in low- and middle-income countries. Antiviral Res. 2015;119:89\u201396.","journal-title":"Antiviral Res"},{"key":"14088_CR46","unstructured":"Global hepatitis report 2024: action for access in low- and middle-income countries. 2024, April, 9. https:\/\/www.who.int\/publications\/i\/item\/9789240091672). World Health Organization."},{"issue":"4","key":"14088_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S2468-1253(23)00449-1","volume":"9","author":"N Minier","year":"2024","unstructured":"Minier N, Guingan\u00e9 AN, Okeke E, Sinkala E, Johannessen A, Andersson MI, et al., \u2026 Sombi\u00e9 R. Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study. Lancet Gastroenterol Hepatol. 2024;9(4):323\u201332.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"14088_CR48","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S2468-1253(25)00015-9","volume":"10","author":"JP Vincent","year":"2025","unstructured":"Vincent JP, S\u00e9g\u00e9ral O, Kania D, Borand L, Adoukara J-P, Pivert A, et al. \u2026 HBcrAg-RDT Study Group. Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy study. Lancet Gastroenterol Hepatol. 2025;10(5):452\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"14088_CR49","unstructured":"Balkandjieva A. CHAI and the hepatitis fund announce pricing breakthrough to reduce cost of viral hepatitis treatment by over 90 percent - hepCoalition. 2023. https:\/\/hepcoalition.org\/en\/news\/partner-news\/article\/chai-and-the-hepatitis-fund-announce-pricing-breakthrough-to-reduce-cost-of."},{"key":"14088_CR50","unstructured":"Ministry of Health. Circular 20\/2022\/TT-BYT promulgate a list, rates, and payment conditions for chemical drugs pharmaceuticals, biologicals, radiopharmaceuticals and tracers fall within the scope benefit of the social healthcare insurance. Hanoi, Vietnam; 2022."},{"key":"14088_CR51","doi-asserted-by":"crossref","unstructured":"Holt B, Mendoza J, Nguyen H, Doan D, Nguyen VH, Cabauatan DJ, et al., \u2026 Duong D. Barriers and enablers to people-centred viral hepatitis care in Vietnam and the Philippines: results of a patient journey mapping study. J Viral Hepat. 2024;31(7):391\u2013403.","DOI":"10.1111\/jvh.13944"},{"key":"14088_CR52","volume-title":"Health systems in transition","author":"MM Dayrit","year":"2018","unstructured":"Dayrit MM, Lagrada LP, Picazo OF, Pons MC, Villaverde MC. The Philippines health system review. In: Health systems in transition. Vol. 8. World Health Organization. Regional Office for South-East Asia; 2018."},{"key":"14088_CR53","doi-asserted-by":"publisher","DOI":"10.2900\/770162","volume-title":"Models of good practice for community-based testing, linkage to care and adherence to treatment for hepatitis B and C, HIV, and tuberculosis and for health promotion interventions to prevent infections among people who inject drugs","author":"I Horv\u00e1th","year":"2023","unstructured":"Horv\u00e1th I. Models of good practice for community-based testing, linkage to care and adherence to treatment for hepatitis B and C, HIV, and tuberculosis and for health promotion interventions to prevent infections among people who inject drugs. European Centre for Disease Prevention and Control; 2023. https:\/\/doi.org\/10.2900\/770162."},{"key":"14088_CR54","doi-asserted-by":"crossref","unstructured":"Duong DB, Holt B, Munoz C, Pollack TM. For and with people: announcing the Lancet global health commission on people-centred care for universal health coverage and a call for commissioner nominations. Lancet Global Health. 2024 1090;12(7):e1089\u2013e.","DOI":"10.1016\/S2214-109X(24)00216-X"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14088-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:31:12Z","timestamp":1781631072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14088"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14088-y","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the respective ethics committees in the United States, Viet Nam, and the Philippines. In the US, approval was granted by the Mass General Brigham Institutional Review Board (protocol number 2022P001836). In Viet Nam, approval was granted by the Hanoi University of Public Health Institutional Review Board (decision numbers 732\/QD-DHYTCC and 560\/QD-DHYTCC). In the Philippines, approval was granted by the University of the Philippines Manila Research Ethics Board (UPMREB code UPMREB 2022\u20130401\u201301). All participants provided informed consent prior to participation in the survey and focus group discussions. All study procedures were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Martin Fernandez, Geohari Hamoy, Jhaki Mendoza, Timothy Bill Mercado, Janus Ong, Jan Philip Florendo, Danica Delima, Mary Cris Rambaoa, Jose Dela Cruz, Hoang Nguyen, My Dang, Thuy Pham, Todd Pollack, David Duong, and Bethany Holt received funding support from Gilead Sciences through a grant or subcontract to their institutions. All other authors have no financial conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}